Table 1. Patients’ characteristics and mortality.
| All (n = 194) | 28-day mortality | 90-day mortality | |||||
|---|---|---|---|---|---|---|---|
| Non-survivors (n = 49) | Survivors (n = 145) | P-valuea | Non-survivors (n = 61) | Survivors (n = 133) | P-valuea | ||
| Baseline characteristics | |||||||
| Age (median with IQR) | 56 (46–63) | 58 (49–69.5) | 54 (46–61) | 0.01 | 59 (49–68.5) | 54 (45.5–59.5) | 0.002 |
| Sex (male) | 129 (66%) | 30 (61%) | 99 (68%) | 0.37 | 38 (62%) | 91 (68%) | 0.40 |
| Sex (female) | 67 (34%) | 19 (39%) | 46 (32%) | 0.37 | 23 (38%) | 42 (32%) | 0.40 |
| Pre-existing conditions | |||||||
| Diabetes | 112 (58%) | 24 (49%) | 88 (61%) | 0.37 | 38 (62%) | 91 (68%) | 0.40 |
| Chronic liver disease | 7 (4%) | 3 (6%) | 4 (3%) | 0.37 | 3 (5%) | 4 (3%) | 0.68 |
| Renal disease | 34 (17.5%) | 14 (29%) | 20 (14%) | 0.02 | 17 (28%) | 17 (13%) | 0.01 |
| Heart disease | 23 (12%) | 7 (14%) | 16 (11%) | 0.61 | 11 (18%) | 12 (9%) | 0.07 |
| Previous melioidosis | 5 (2.5%) | 1 (2%) | 4 (3%) | 1.00 | 2 (3%) | 3 (2%) | 0.65 |
| Clinical presentations | |||||||
| Bacteremia | 99 (51%) | 37 (75.5%) | 62 (43%) | < 0.001 | 45 (74%) | 54 (41%) | < 0.001 |
| Pneumonia | 48 (25%) | 15 (31%) | 33 (23%) | 0.27 | 18 (29.5%) | 30 (22.5%) | 0.30 |
a For categorical variables, P values were determined with Pearson’s chi squared test or Fisher’s exact test for cells with value <10. For continuous variables, P values were determined with the Mann-Whitney U-test.